Zeidner Explains Transformation to AML in Higher-Risk MDS On OncLive.
August 15, 2021
Joshua F. Zeidner, MD, associate professor of medicine in the division of hematology, discussed the risk of transformation to acute myeloid leukemia (AML) in higher-risk myelodysplastic syndromes (HR-MDS), recently on OncLiveTV. Watch OncLive TV.